ZENG; Li-Fan Patent Filings

Patent	Date
Methods Of Treating Autoimmune And/or Glomerulonephritis-associated Diseases Using Shp2 Inhibitors App 20190000801 - ZHANG; Zhong-Yin ; et al.	2019-01-03
Methods of treating autoimmune and/or glomerulonephritis-associated diseases using SHP2 inhibitors Grant 10,092,543 - Zhang , et al. October 9, 2	2018-10-09
Methods Of Treating Autoimmune And/or Glomerulonephritis-associated Diseases Using Shp2 Inhibitors App 20180071252 - ZHANG; Zhong-Yin ; et al.	2018-03-15
SHP2 inhibitors and methods of treating autoimmune and/or glomerulonephritis-associated diseases using SHP2 inhibitors Grant 9,844,535 - Zhang , et al. December 19, 2	2017-12-19
Shp2 Inhibitors And Methods Of Treating Autoimmune And/or Glomerulonephritis-associated Diseases Using Shp2 Inhibitors App 20160374988 - ZHANG; Zhong-Yin ; et al.	2016-12-29
Hydroxyindole carboxylic acid based inhibitors for oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) Grant 9,522,881 - Zhang , et al. December 20, 2	2016-12-20
Tyrosine phosphatase inhibitors and uses thereof to modulate the activity of enzymes involved in the pathology of Mycobacterium tuberculosis Grant 9,493,436 - Zhang , et al. November 15, 2	2016-11-15
Hydroxyindole Carboxylic Acid Based Inhibitors For Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (shp2) App 20160102054 - Zhang; Zhong-Yin ; et al.	2016-04-14
TYROSINE PHOSPHATASE INHIBITORS AND USES THEREOF TO MODULATE THE ACTIVITY OF ENZYMESp INVOLVED IN THE PATHOLOGY OF MYCOBACTERIUM TUBERCULOSIS App 20140179735 - Zhang; Zhong-Yin ; et al.	2014-06-26

Patent

Date

Methods Of Treating Autoimmune And/or Glomerulonephritis-associated Diseases Using Shp2 Inhibitors
App 20190000801 - ZHANG; Zhong-Yin ; et al.

2019-01-03

Methods of treating autoimmune and/or glomerulonephritis-associated diseases using SHP2 inhibitors
Grant 10,092,543 - Zhang , et al. October 9, 2

2018-10-09

Methods Of Treating Autoimmune And/or Glomerulonephritis-associated Diseases Using Shp2 Inhibitors
App 20180071252 - ZHANG; Zhong-Yin ; et al.

2018-03-15

SHP2 inhibitors and methods of treating autoimmune and/or glomerulonephritis-associated diseases using SHP2 inhibitors
Grant 9,844,535 - Zhang , et al. December 19, 2

2017-12-19

Shp2 Inhibitors And Methods Of Treating Autoimmune And/or Glomerulonephritis-associated Diseases Using Shp2 Inhibitors
App 20160374988 - ZHANG; Zhong-Yin ; et al.

2016-12-29

Hydroxyindole carboxylic acid based inhibitors for oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)
Grant 9,522,881 - Zhang , et al. December 20, 2

2016-12-20

Tyrosine phosphatase inhibitors and uses thereof to modulate the activity of enzymes involved in the pathology of Mycobacterium tuberculosis
Grant 9,493,436 - Zhang , et al. November 15, 2

2016-11-15

Hydroxyindole Carboxylic Acid Based Inhibitors For Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (shp2)
App 20160102054 - Zhang; Zhong-Yin ; et al.

2016-04-14

TYROSINE PHOSPHATASE INHIBITORS AND USES THEREOF TO MODULATE THE ACTIVITY OF ENZYMESp INVOLVED IN THE PATHOLOGY OF MYCOBACTERIUM TUBERCULOSIS
App 20140179735 - Zhang; Zhong-Yin ; et al.

2014-06-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

ZENG; Li-Fan

Patent Applications and Registrations